business
BofA raises argenx stock price target to $1,088 on myositis data
BofA raises argenx stock price target to $1,088 on myositis data
Read full story on Investing.com → More top storiesAlso covered by
Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop